R97.21: Rising PSA following treatment for malignant neoplasm of prostate
R97.21 is the billable ICD-10-CM diagnosis code for Rising PSA following treatment for malignant neoplasm of prostate. It is a fully specified code, so it can be reported on a claim (subject to clinical documentation and your payer's rules).
Frequently asked questions
What is ICD-10-CM code R97.21?
R97.21 is the ICD-10-CM diagnosis code for Rising PSA following treatment for malignant neoplasm of prostate. It belongs to category R97 (Abnormal tumor markers).
Is R97.21 a billable code?
Yes. R97.21 is a billable, fully specified ICD-10-CM code, so it can be used on a claim (subject to documentation and payer rules).
What category does R97.21 belong to?
R97.21 is part of ICD-10-CM category R97 — Abnormal tumor markers, which has 10 billable codes.
More free billing tools: all ICD-10 categories · ICD-10 search · denial codes · Medicare fees
Informational only, not coding or medical advice. Verify against the official ICD-10-CM (FY2026) and your payer's guidelines.
Code the diagnosis right
Join providers across the country delivering modern virtual care with CareNiva. Free to start, ready in minutes.
100% Satisfaction Guaranteed — try it risk-free